The first prostate cancer patient has been treated with the electromagnetic tumor tracking system, RayPilot® at the private hospital Gayrettepe Florence Nightingale hospital in Istanbul, Turkey.
RayPilot tracks prostate motion continuously during radiotherapy in order to make sure that the radiation is delivered to the right spot and to minimise dangerous radiation to healthy surrounding tissue.
"We are proud to be the first clinic to offer the RayPilot to our prostate cancer patients in Turkey. Our goal is to go into hypofractionated protocols where motion detection of the target is crucial" says Şefik İğdem
medical doctor and professor at the Gayrettepe Florence Nightingale Hospital.
The Gayrettepe Florence Nightingale hospital is the first hospital in Turkey to use this equipment and has the goal to decrease the number of treatments from around 40 to 5 with less radiation to the healthy tissue.
Mecit Canbolat, General Manager of the RayPilot distributor Oncotech, says: “Gayrettepe Florence Nightingale hospital is one of the best-known facilities in Turkey. RayPilot is the perfect match for a department that needs to have a sophisticated treatment for hypofractionated protocols. This cooperation will help improve treatment quality for patients and should inspire other clinics.”